How can we help you?

Modern mass spectrometry developments hold significant potential for the discovery and sensitive detection of innovative (sets of) biomarkers which will allow rapid and accurate diagnosis of multiple disorders simultaneously in a single patient’s small-volume sample.

ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., peptides) in clinically sampled human tissues and biofluids.

Founder and industry support

ProteoFormiX was founded by Prof. Dr. Peter Verhaert in 2017. The company resides at JLABS@BE, the European Johnson & Johnson Innovation Center. ProteoFormiX is supported by BlueHealth InnovationEIT HealthFlanders Innovation and Entrepreneurship (VLAIO) and Imec.istart.

Company profile

“The value of the extensive incubator management expertise offered by Bioqube Ventures, along with direct access to the largest European Life Science R&D ecosystem based at the Janssen campus in Beerse is priceless for a start-up like ProteoFormiX.”

Contact us

If you wish to get in touch with us at ProteoFormiX, send us an e-mail through contact[at]proteoformix.com or try our contact page.

ProteoFormiX.png
  • LinkedIn

powered by:

© 2020 ProteoFormiX

imecistart.png
BlueHealth.png
eithealth.png
FIE-sponsorlogo.png